FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 329 of 329

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
TRVN Over the counter Trevena, Inc. 2836
TSBX Nasdaq Turnstone Biologics Corp. 2836
TTNP Nasdaq Titan Pharmaceuticals, Inc. 2836
TVRD Nasdaq Tvardi Therapeutics, Inc. 2836
TVTX Nasdaq Travere Therapeutics, Inc. 2836
TWST Nasdaq Twist Bioscience Corporation 2836
TXG Nasdaq 10x Genomics, Inc. 2836
TYRA Nasdaq Tyra Biosciences, Inc. 2836
URGN Nasdaq UroGen Pharma Ltd. 2836
VERA Nasdaq Vera Therapeutics, Inc. 2836
VIVS Nasdaq VivoSim Labs, Inc. 2836
VOR Nasdaq Vor Biopharma Inc. 2836
VRDN Nasdaq Viridian Therapeutics, Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VTGN Nasdaq Vistagen Therapeutics, Inc. 2836
VXRT Nasdaq Vaxart, Inc. 2836
VYGR Nasdaq Voyager Therapeutics, Inc. 2836
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2836
WINT Nasdaq Windtree Therapeutics, Inc. 2836
XENE Nasdaq Xenon Pharmaceuticals Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
XNCR Nasdaq Xencor, Inc. 2836
YMAB Nasdaq Y-mAbs Therapeutics, Inc. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZEOX Over the counter Zeo ScientifiX, Inc. 2836
ZLAB Nasdaq Zai Lab Limited 2836
ZLDPY Over the counter Zealand Pharma A/S 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
ZYME Nasdaq Zymeworks Inc. 2836
Results 300 through 329 of 329